Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
Economic analysis of simvastat...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
Detalles Bibliográficos
Main Authors:
Mihaylova, B
,
Armitage, J
,
Briggs, A
,
Gray, A
,
Parish, S
,
Collins, R
,
Collaborati, H
Formato:
Conference item
Publicado:
2005
Existencias
Descripción
Títulos similares
Staff View
Títulos similares
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
por: Mihaylova, B, et al.
Publicado: (2005)
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
por: Mihaylova, B, et al.
Publicado: (2006)
N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
por: Emberson, J, et al.
Publicado: (2005)
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
por: Armitage, J, et al.
Publicado: (2009)
N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
por: Emberson, J, et al.
Publicado: (2005)